December
19
  11:37:00 PM

Are embryonic stem cells ideal for drug testing?

One possible use for controversial human embryonic stem cells, apart from possible therapies and research into genetic diseases, is testing new drugs to see whether they might be toxic in humans. Animal trials are often unreliable, as compounds which appear to be safe in animals may harm people. Now Gabriela Cezar, an animal scientist at the University of Wisconsin-Madison, has begun investigating whether the stem cells will actually work. The answer, it seems, is "not yet".

She tested a drug which is known to produce birth defects, valproate, and measured changes in the concentrations of certain molecules. However, a scientist at MIT, Steven Tannenbaum, says that whether her results are useful is still unclear. The liver metabolises drugs into other forms. "This group has taken valproic acid, which is normally extensively metabolised in the body, and exposed it under unrealistic conditions." Cezar acknowledges this and says that the problem might be overcome by morphing embryonic stem cells into liver cells before testing them. ~ Technology Review, Dec 13




 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Indian surrogate for US woman dies in Gurjarat
18 May 2012
Do reproductive rights survive gender reassignment?
19 May 2012
South African activists begin euthanasia campaign
19 May 2012
70 assisted suicides in Washington state in 2011
19 May 2012
Would-be grandparents pay for their daughters’ egg freezing
19 May 2012

 Tags
organ donation, sex selection, bioethics, Canada, embryonic stem cells, clinical trials, India, genetic testing, abortion, commercialization, China, human drama, law, suicide, surrogacy, Down syndrome, assisted suicide, neuroscience, research, US, sperm donation, informed consent, organ transplants, stem cells, Australia, UK, organ trafficking, IVF, Netherlands, euthanasia,